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KEYWORDS	
	 The	typical	active	methyl	functionality	of	6,8‐dichloro‐2‐methyl‐4H‐chromen‐4‐one	is	utilized
to	 obtain	 2‐styrylchromones,	 pyruvate	 ester	 and	 phthalide	 via	 reactions	 with	 aromatic
carboxaldehydes,	diethyl	oxalate	and	phthalic	anhydride	respectively.	The	phthalide	provides
illustrative	example	 to	convert	a	heterocyclic	 compound	to	an	aliphatic	one	via	 the	effect	of
alcoholic	 sodium	methoxide.	Bromination	 and	 cycloaddition	 reactions	 of	 2‐styrylchromones
afford	 vicinal	 dibromide	 and	 adducts	 respectively.	 This	 work	 presents	 to	 the	 art	 a	 typical
example	 of	 heterocyclic	 systems	 transformations	 through	 the	 conversion	 of	 the	 starting
chromone	to	coumarin	under	the	influence	of	thionyl	chloride	followed	by	aqueous	potassium
hydroxide.	 Some	 heterocyclic	 systems	 like	 pyrazole,	 isoxazol	 and	 quinolinone	 are	 obtained
from	 the	 target	 chromone	 by	 treatment	with	 hydrazines,	 hydroxylamine	hydrochloride	 and
ammonium	 acetate	 respectively.	 Thiation	 of	 starting	 chromone	 interestingly	 affords	 a
dithiated	 product	 instead	 of	 the	 expected	 monothiated	 one.	 Antibacterial	 and	 antifungal
activities	of	some	synthesized	compounds	have	been	screened.	
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1.	Introduction	
	
2‐Methylchromones	 and	 their	 derivatives	 are	well	 known	
naturally	 occurring	 oxygen‐containing	 heterocyclic	
compounds,	 which	 perform	 important	 biological	 functions	 in	
nature.	It	is	known	that	certain	natural	and	synthetic	chromone	
derivatives	 possess	 important	 biological	 activities,	 such	 as	
cytotoxic	 (anticancer)	 [1‐7],	 antihepatotoxic,	 antioxidant	 [8,9],	
anti‐inflammatory	 [10],	 antispasmodic,	 estrogenic	 [11],	
antimicrobial	 [12‐14],	 antifungal	 [15],	 antibacterial	 [16‐18],	
and	HIV‐inhibition	 [19].	Due	 to	 their	 abundance	 in	plants	and	
their	 low	 mammalian	 toxicity,	 chromone	 derivatives	 are	
present	in	large	amounts	in	the	diets	of	human	[20,21].	
In	continuation	of	our	previous	works	[22‐24],	the	present	
report	 aimed	 at	 utilization	 of	 the	 reactivity	 of	 6,8‐dichloro‐2‐
methyl‐4H‐chromen‐4‐one	 (2)	 towards	 nitrogen	 and	 carbon	
nucleophiles	 to	 get	 new	 derivatives	 and	 evaluated	 them	 for	
antifungal	and	antibacterial	activities.	
	
2.	Experimental	
	
2.1.	Instrumentation	
		
All	melting	points	were	measured	on	a	Gallenkamp	electric	
melting	 point	 apparatus	 and	 are	 uncorrected.	 The	 infrared	
spectra	were	recorded	using	potassium	bromide	disks	on	a	Pye	
Unicam	SP‐3‐300	infrared	spectrophotometer.	1H	NMR	and	13C	
NMR	experiments	were	 run	 at	300	MHz	on	 a	Varian	Mercury	
VX‐300	 NMR	 spectrometer	 using	 tetramethylsilane	 (TMS)	 as	
internal	 standard	 in	 deuterated	 chloroform	 or	 dimethyl	
sulphoxide.	Chemical	 shifts	are	quoted	as	δ.	The	mass	spectra	
were	 recorded	 on	 Shimadzu	 GCMS‐QP‐1000EX	mass	 spectro‐
meters	at	70	eV.	All	 the	 spectral	measurements	as	well	as	 the	
elemental	 analyses	 were	 carried	 out	 at	 the	 Micro	 analytical	
Center	 of	 Cairo	 University.	 All	 the	 newly	 synthesized	
compounds	gave	satisfactory	elemental	analyses.		
	
2.2.	Synthesis	
	
2.2.1.	6,8‐Dichloro‐2‐styryl‐4H‐chromen‐4‐one	(3a),	2‐(4‐
fluorostyryl)‐6,8‐dichloro‐4H‐chromen	‐4‐one	(3b)	and	2‐(4‐
methoxystyryl)‐6,8‐dichloro‐4H‐chromen‐4‐one	(3c)	
	
To	 a	 solution	 of	 2‐methylchromone	 derivative	 (2)	 (10	
mmol,	2.29	g)	in	dry	ethanol	(20	mL),	the	appropriate	aldehyde	
such	 as	 benzaldehyde,	 4‐flourobenzaldehyde	 and	 4‐
methoxybenzaldehyde	 (10	 mmol)	 was	 added.	 The	 reaction	
mixture	was	stirred	at	room	temperature	for	2h	in	the	presence	
of	sodium	ethoxide	(prepared	by	reaction	0.33	g	sodium	metal	
with	 10	mL	 dry	 ethanol).	 The	 solid	 product	 that	 formed	was	
collected	 by	 suction,	 dried	 and	 then	 recrystallised	 from	
benzene	(Scheme	1).	
6,8‐Dichloro‐2‐styryl‐4H‐chromen‐4‐one	 (3a):	 Pale	 brown	
crystals.	Yield:	96%.	M.p.:	163‐166	oC.	FT‐IR	(KBr,	cm‐1):	1658	
(C=O)(chromone),	 1631	(C=C).	 1H	NMR	 (300	MHz,	 CDCl3,	 δ,	
ppm):	8.08‐7.40	(m,	7H,	Ar‐H),	6.83	(d,	1H,	 ‐CH=CH‐),	6.78	(d,	
1H,	 ‐CH=CH‐),	 6.35	 (s,	 1H,	 pyran	 ring).	 MS	 (EI,	m/z,	 %):	 316	
(M+.,	 25.1).	 Anal.	 calcd.	 for	 C17H10Cl2O2:	 C,	 64.38;	 H,	 3.18;	 Cl,	
22.36;	Found:	C,	64.24;	H,	2.98,	Cl,	22.24%.	
2‐(4‐fluorostyryl)‐6,8‐dichloro‐4H‐chromen‐4‐one	 (3b):	Pale	
brown	crystals.	Yield:	63%.	M.p.:	186‐188	oC.	FT‐IR	(KBr,	cm‐1):	
1649	(C=O)	(chromone).		
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(i)	 Conc	H2SO4,	 stirring,	 rt;	 (ii)	 Ar‐CHO,	 EtONa,	 EtOH,	 stirring;	 (iii)	 Br2	 /	 AcOH,	 stirring;	 (iv)	 fusion;	 (v)	 SOCl2,benzene,	 reflux;	 (vi)	 10%	 alc.KOH,	 reflux;(vii)	
Diethyloxalate,	dry	diethyl	ether	,	sodium	metal,	stirring,	rt;	(viii)	phthalic	anhydride,	sodium	acetate,	fusion;	(ix)	MeONa,	MeOH,	reflux;	(x)	EtONa,	diethyl	ether,	
rt.	
	
Scheme	1
	
	
1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	8.16‐7.60	(m,	6H,	Ar‐
H),	 7.33	 (d,	 1H,	 ‐CH=CH‐),	 7.24	 (d,	 1H,	 ‐CH=CH‐),	 6.54	 (s,	 1H,	
pyran	ring).	13C	NMR	(75	MHz,	DMSO‐d6,	δ,	ppm):		175.0	(C‐3),	
161.6	(C‐1	&	C‐6'),	149.8	(C‐9),	135.9	(C‐7),	133.4	(C‐2'),	131.2	
(C‐6),	130.1	(C‐3'),	130.0	(C‐5),	129.4	(C‐4'),	125.4	(C‐8),	123.0	
(C‐4),	119.9	(C‐1'),	116.0	(C‐5'),	110.0	(C‐2)	(Scheme	2).	MS	(EI,	
m/z,	%): 334	(M+.,	27.4).	Anal.	calcd.	for	C17H9Cl2FO2:	C,	60.92;	
H,	2.71;	Cl,	21.16.	Found:	C,	60.84;	H,	2.59;	Cl,	21.00%.	
2‐(4‐methoxystyryl)‐6,8‐dichloro‐4H‐chromen‐4‐one	 (3c):	
Green	crystals.	Yield:	38%.	M.p.:	195‐198	oC.	FT‐IR	(KBr,	cm‐1):	
1652	 (C=O)	 (chromone),	 1643	 (C=C).	 1H	 NMR	 (300	 MHz,	
DMSO‐d6,	 δ,	 ppm):	 8.07‐7.35	 (m,	 6H,	 Ar‐H),	 7.05	 (d,	 1H,	 ‐
CH=CH‐),	6.98	 (d,	1H,	 ‐CH=CH‐),	 6.44	 (s,	1H,	pyran	 ring),	3.79	
(S,	3H,	‐OCH3).	MS	(EI,	m/z,	%):	348	(M+2 ,	27.8).	Anal.	calcd.	
for	C18H12Cl2O3:	C,	62.27;	H,	3.48;	Cl,	20.42.	Found:	C,	62.14;	H,	
3.38;	Cl,	20.20%.	
2.2.2.	6,8‐Dichloro‐2‐(1,2‐dibromo‐2‐phenylethyl)‐4H‐
chromen‐4‐one	(4)		
	
To	 a	 solution	 of	 compound	3a	 (4	mmol,	 1.28	 g)	 in	 glacial	
acetic	acid	 (30	mL),	bromine	 (3	mmol,	0.5	g)	 in	acetic	acid	 (3	
mL)	was	added.	The	reaction	mixture	was	stirred	for	0.5	h,	and	
left	to	overnight	at	room	temperature.	The	crude	solid	product	
that	 deposited	 was	 collected	 by	 suction,	 washed	 with	 water,	
dried	 and	 then	 recrystallised	 from	 light	 petroleum	 ether	 (80‐
100	 oC)	 and	 benzene	 to	 give	 vicinal	 dibromochromone	
derivative	4	 as	 orange	 crystals	 (Scheme	 1).	 Yield:	 58%.	M.p.:	
179‐182	oC.	FT‐IR	(KBr,	cm‐1):	1660	(C=O)	chromone.	1H	NMR	
(300	MHz,	CDCl3,	δ,	ppm):	8.16‐7.40	(m,	7H,	Ar‐H),	7.23	(s,	1H,	
pyran	ring),	6.07	(d,	1H,	Br‐CH‐CH‐Br,	J	=	11.7	Hz),	5.65	(d,	1H,	
Br‐CH‐CH‐Br,	 J	 =	 11.7	 Hz).	 MS	 (EI,	m/z,	 %):	 474	 (M+.,	 33.7).	
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Anal.	 calcd.	 for	 C17H10Br2Cl2O2:	 C,	 42.81;	 H,	 2.11;	 Cl,	 14.87.	
Found:	C,	42.69;	H,	1.98;	Cl,	14.69%.	
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Scheme	2	
	
	
2.2.3.	7,9‐Dichloro‐4‐phenyl‐1H‐furo[3,4‐a]xanthene‐1,3,11‐
trione	(5a)	
	
A	 mixture	 of	 2‐styryl	 derivative	 3a	 (2	 mmol)	 and	 maleic	
anhydride	 (20	mmol)	 in	molar	 ratio	 1:10	was	 fused	 on	 sand	
bath	at	fused	temperature	for	3	h	and	left	to	cool.	The	solid	that	
formed	 was	 triturated	 with	 warm	 ethanol,	 filtered	 and	
recrystallized	from	ethanol	to	afford	xanthone	derivative	5a	as	
brown	 crystals	 (Scheme	 1).	 Yield:	 58%.	 M.p.:	 >300	 oC.	 FT‐IR	
(KBr,	 cm‐1):	 br.	 centered	 at	 1722	 (C=O)	 anhydride,	 1631	
(C=O)	(chromone).	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	8.18‐
7.26	(m,	7H,	Ar‐H),	6.58	(s,	1H,	C5‐H).	MS	(EI,	m/z,	%):	315	(M‐
C4O3,+H ,	17.8).	Anal.	 calcd.	 for	C21H8Cl2O5:	C,	61.34;	H,	1.96;	
Cl,	17.24.	Found:	C,	61.22;	H,	1.78;	Cl,	17.17%.	
	
2.2.4.	Reaction	of	2‐styrylchromone	derivatives	(3b,c)	with	
N‐Arylmaliemides;	formation	of	adducts	(5b‐g)		
	
2	mmol	 of	 2‐Styryl	 derivatives	 (3b,	c)	was	 fused	with	 the	
appropriate	N‐arylmaliemide	 (4	 mmol)	 in	molar	 ratio	 1:2	 on	
sand	bath	at	 fused	 temperature	 for	 3	h;	 left	 to	 cool.	The	 solid	
that	 formed	 was	 triturated	 with	 warm	 ethanol;	 filtered	 and	
recrystallised	 from	 the	 proper	 solvent	 to	 afford	 the	 expected	
adducts	(5b‐g)	(Scheme	1).		
7,9‐Dichloro‐4‐(4‐fluorophenyl)‐2‐phenylchromeno[3,2‐e]	
isoindole‐1,3,11(2H)‐trione	(5b):	Recrystallized	from	acetic	acid	
to	 afford	 the	adduct	 as	brown	crystals.	Yield:	80%.	M.p.:	 197‐
200	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 1776,	 1707	(C=O)	 imide..	 1H	NMR	
(300	MHz,	CDCl3,	δ,	ppm):	8.10‐7.10	(m,	11H,	Ar‐H),	6.36	(s,	1H,	
C5‐H).	 MS	 (EI,	 m/z,	 %):	 503	 (M+.,	 50).	 Anal.	 calcd.	 for	
C27H12Cl2FNO4:	 C,	 64.31;	 H,	 2.40;	 Cl,	 14.06;	 N,	 2.78.	 Found:	 C,	
64.22;	H,	2.35;	Cl,	13.97;	N,	2.67%.		
7,9‐Dichloro‐4‐(4‐fluorophenyl)‐2‐(4‐nitrophenyl)chromeno	
[3,2‐e]isoindole‐1,3,11(2H)‐trione	 (5c):	 Recrystallised	 from	
ethanol	to	afford	the	adduct	as	brown	crystals.	Yield:	51%.	M.p.:	
200‐202	oC.	FT‐IR	(KBr,	cm‐1):	1670,1656		(C=O)	imide,	1633	
(C=O)	 (chromone).	 1H	 NMR	 (300	MHz,	 CDCl3,	 δ,	 ppm):	 8.23‐
6.34	 (m,	 10H,	 Ar‐H),	 6.31(s,	 1H,	 C5‐H).	 MS	 (EI,	m/z,	 %):	 (M‐
C10H4O4N2,‐2H ,	 19.1).	 Anal.	 calcd.	 for	 C27H11Cl2FN2O6:	 C,	
59.04;	 H,	 2.02;	 Cl,	 12.91;	 N,	 5.10.Found:	 C,	 58.96;	 H,	 1.98;	 Cl,	
12.79;	N,	4.97%.	
7,9‐Dichloro‐4‐(4‐fluorophenyl)‐2‐(4‐methoxyphenyl)	
chromeno[3,2‐e]isoindole‐1,3,11(2H)‐trione	 (5d):	Recrystallised	
from	ethanol	to	afford	the	adduct	as	brown	crystals.	Yield:	75%.	
M.p.:	202‐205	oC.	FT‐IR	(KBr,	cm‐1):	1708,	1656	(C=O)	 imide,	
1634	(C=O)	chromone.	 1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	
8.13‐7.17	(m,	10H,	Ar‐H),	6.52	(s,	1H,	C5‐H),	3.39	(s,	3H,	‐OCH3).	
MS	 (EI,	 m/z,	 %):	 538	 (M+5 ,	 80.0).	 Anal.	 calcd.	 for	
C28H14Cl2FNO5:	 C,	 62.94;	 H,	 2.64;	 Cl,	 13.27;	 N,	 2.62.	 Found	 C,	
62.78;	H,	2.49;	Cl,	13.15;	N,	2.56%.	
7,9‐Dichloro‐4‐(4‐methoxyphenyl)‐2‐phenylchromeno[3,2‐e]	
isoindole‐1,3,11(2H)‐trione	(5e):	Recrystallised	from	acetic	acid	
to	afford	the	adduct	as	brown	crystals.	Yield:	79%.	M.p.:	>300	
oC.	FT‐IR	 (KBr,	 cm‐1):	1771,	1721	(C=O)	 imide,.	 1H	NMR	(300	
MHz,	DMSO‐d6,	δ,	ppm):	7.47‐7.28	 (m,	11H,	Ar‐H),	6.50	(s,	1H,	
C5‐H),	3.83	(s,	3H,	 ‐OCH3).	MS	(EI,	m/z,	%):	519	(M+4 ,	2.0).	
Anal.	 calcd.	 for	 C28H15Cl2NO5:	 C,	 65.13;	 H,	 2.93;	 Cl,	 13.73;	 N,	
2.71.	Found:	C,	64.98;	H,	2.79;	Cl,	13.69;	N,	2.64%.	
7,9‐Dichloro‐4‐(4‐methoxyphenyl)‐2‐(4‐nitrophenyl)	
chromeno[3,2‐e]isoindole‐1,3,11(2H)‐trione	 (5f):	 Recrystallised	
from	acetic	acid	 to	afford	 the	adduct	 as	brown	crystals.	Yield:	
63%.	 M.p.:	 	 >300	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 1729,	 1643	 (C=O)	
imide..	 1H	NMR	 (300	MHz,	DMSO‐d6,	 δ,	 ppm):	 7.96‐7.92,	 6.68‐
6.57	 (2	 m,	 11H,	 Ar‐H),	 3.30	 (s,	 3H,	 ‐OCH3).	 Anal.	 calcd.	 for	
C28H14Cl2N2O7:	 C,	 59.91;	 H,	 2.51;	 Cl,	 12.63;	 N,	 4.99.	 Found:	 C,	
59.78;	H,	2.45;	Cl,	12.57;	N,	4.79%.	
7,9‐Dichloro‐2,4‐bis(4‐methoxyphenyl)chromeno[3,2‐e]	
isoindole‐1,3,11(2H)‐trione	(5g):	Recrystallized	from	acetic	acid	
to	afford	the	adduct	as	brown	crystals.	Yield:	64%.	M.p.:	>300	
oC.	 FT‐IR	 (KBr,	 cm‐1):	 1768,	 1716	(C=O)	 imide,	 1642	(C=O)	
chromone.	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	7.43‐7.05	(m,	
11H,	Ar‐H),	3.87	(s,	3H,	‐OCH3),	3.82	(s,	3H,	‐OCH3).	MS	(EI,	m/z,	
%):	547	(M+2 ,	43.8).	Anal.	calcd.	 for	C29H17Cl2NO6:	C,	63.75;	
H,	3.14;	Cl,	12.98;	N,	2.56.	Found:	C,	63.68;	H,	3.08;	Cl,	12.82;	N,	
2.47%.	
	
2.2.5.	6,8‐Dichloro‐2‐(trichloromethyl)‐4H‐chromen‐4‐one	
(6)		
	
A	 mixture	 of	 chromone	 derivative	 2	 (5	 mmol,	 1.14	 g)	 in	
benzene	 (15	mL)	 and	 thionyl	 chloride	 (20	mmol,	 2.37	 g)	was	
heated	at	reflux	temperature	for	3	h	and	 left	 to	cool	 .the	solid	
product	that	formed	was	filtered,	dried	and	recrystallized	from	
benzene	to	afford	compound	6	as	dark	brown	crystals	(Scheme	
1).	 Yield:	 31%.	 M.p.:	 178‐180	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 1657	
(C=O)	chromone.	 1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	8.24‐
7.78	 (m,	 2H,	 Ar‐H),	 6.98	 (s,	 1H,	 pyran	 ring).	MS	 (EI,	m/z,	%):	
331	(M+1 ,	27.5).	Anal.	calcd.	for	C10H3Cl5O2:	C,	36.13;	H,	0.91;	
Cl,	53.33.	Found:	C,	36.04;	H,	0.72;	Cl,	53.13%.	
	
2.2.6.	6,8‐Dichloro‐4‐hydroxy‐2H‐chromen‐2‐one	(7)	
	
A	 mixture	 of	 chromone	 derivative	 6	 (4	 mmol,	 1.00	 g)	
aqueous	 ethanolic	 potassium	 hydroxide	 solution	 (10%,	 w/v)	
was	added.	The	reaction	mixture	was	heated	at	reflux	for	11	h.	
The	 reaction	 mixture	 solution	 was	 left	 to	 cool	 and	 then	
acidified	 by	 10%	 cold	 sulfuric	 acid	 to	 give	 the	 crude	 solid	
product	which	was	collected	by	suction,	washed	by	cold	water	
dried	and	then	recrystallised	from	toluene	to	give	compound	7	
as	brown	crystals	(Scheme	1).	Yield:	81%.	M.p.:	>300	oC.	FT‐IR	
(KBr,	cm‐1):	3438	(OH),	1710	(C=O)	coumarin.	1H	NMR	(300	
MHz,	DMSO‐d6,	δ,	ppm):	12.54	(s,	1H,	OH,	exchangeable),	7.98‐
7.71	(s,	2H,	Ar‐H),	6.94	(s,	1H,	pyran	ring).	MS	(EI,	m/z,	%):	216	
(M‐OH+2H ,	3.9).	Anal.	calcd.	for	C9H4Cl2O3:	C,	46.79;	H,	1.75;	
Cl,	30.69.	Found:	C,	46.57;	H,	1.58;	Cl,	30.48%.	
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2.2.7.	Ethyl	3‐(6,8‐dichloro‐4‐oxo‐4H‐chromen‐2‐yl)‐2‐
oxopropanoate	(8)		
	
To	a	mixture	of	chromone	derivative	2	(5	mmol,	1.14	g)	and	
diethyl	oxalate	 (25	mmol,	3.6	g)	 in	dry	diethyl	ether	 (50	mL),	
sodium	metal	(0.5	g)	was	added	at	once.	The	reaction	mixture	
was	 stirred	 for	 0.5	h	 and	 left	 overnight	 at	 room	 temperature.	
Acidification	 with	 cold	 dilute	 acetic	 acid,	 the	 crude	 solid	
product	that	deposited	was	collected	by	suction,	dried	and	then	
recrystallized	from	toluene	to	give	pyruvic	ester	derivative	8	as	
orange	crystals	(Scheme	1	and	2).	Yield:	65%.	M.p.:	218‐220	oC.	
FT‐IR	 (KBr,	 cm‐1):	 1730	 (C=O)	 ketoester,	 1653	 (C=O)	
chromone.	1H	NMR	(300	MHz,	DMSO‐d6,	δ,	ppm):	8.12‐7.84	(2s,	
2H,	Ar‐H),	6.96	(s,	1H,	‐CH=C‐OH),	6.08	(s,	1H,	pyran	ring),	4.30	
(q,	2H,	‐CH2CH3,	J	=	7.2	Hz),	3.75	(s,	1H,	OH,	exchangeable),	1.31	
(t,	 3H,	 ‐CH2CH3,	 J	 =	 7.2	 Hz).	 13C	 NMR	 (75	 MHz,	 DMSO‐d6,	 δ,	
ppm):		184.0	(C‐3),	177.6	(C‐2'),	162.6	(C‐1),	161.1	(C‐3'),	149.9	
(C‐9),	133.4	 (C‐7),	129.4	 (C‐6),	125.1	 (C‐5),	123.5	 (C‐8),	122.8	
(C‐4),	110.3	(C‐1'),	109.3	(C‐2),	62.4	(C‐4'),	14.0	(C‐5').	MS	(EI,	
m/z,	%):	328	(M+.,	47.9).	Anal.	calcd.	 for	C14H10Cl2O5:	C,	51.09;	
H,	3.06;	Cl,	21.54.	Found:	C,	51.00;	H,	2.98;	Cl,	21.32%.	
	
2.2.8.	3,5‐Dichloro‐2‐hydroxybenzoic	acid	(9)		
	
Pyruvic	 ester	 derivative	 8	 (5	 mmol,	 1.6	 g)	 was	 heated	
under	reflux	for	4	h	in	30	mL	of	10%	aq.	potassium	hydroxide.	
Left	to	cool	and	acidified	with	cold	dilute	hydrochloric	acid,	the	
crude	 solid	 product	 that	 deposited	 was	 collected	 by	 suction,	
dried	and	then	recrystallised	from	toluene	to	give	salicylic	acid	
derivative	 9	 as	 crystals	 which	 gave	 positive	 acidity	 test	 and	
deep	violet	coloration	with	aqueous	FeCl3	solution	(Scheme	1).	
Yield:	50%.	M.p.:	220‐222	oC	(the	same	M.p.	in	literature	[25]).	
FT‐IR	(KBr,	cm‐1):	3334	(OH),	1679	(C=O)	acid.	1H	NMR	(300	
MHz,	 CDCl3,	 δ,	 ppm):	 11.07	 (s,	 1H,	 OH	 carboxylic	 acid,	
exchangeable),	7.82	(s,	1H,	Ar‐H),	7.61	(s,	1H,	Ar‐H),	2.67	(s,	1H,	
aromatic	 C‐OH,	 exchangeable).	 MS	 (EI,	m/z,	%):	 208	 (M+2 ,	
2.6).	 Anal.	 calcd.	 for	 C7H4Cl2O3:	 C,	 40.61;	 H,	 1.95;	 Cl,	 34.25.	
Found:	C,	40.44;	H,	1.49;	Cl,	34.15%.	
	
2.2.9.	6,8‐Dichloro‐2‐((3‐oxoisobenzofuran‐1(3H)‐ylidene)	
methyl)‐4H‐chromen‐4‐one	(10)		
	
	A	mixture	of	2‐methylchromone	derivative	2	(9	mmol,	2	g)	
and	phthalic	anhydride	(41	mmol,	6	g)	in	the	presence	of	fused	
sodium	acetate	(36	mmol,	3	g)	was	fused	at	125	oC	for	8	h.	The	
reaction	mixture	was	left	to	cool	at	room	temperature	and	then	
triturated	 by	 aqueous	 sodium	 carbonate	 solution.	 The	 solid	
obtained	 was	 filtered	 off,	 washed	with	 cold	 water,	 dried	 and	
recrystallised	 from	 aqueous	 ethanol	 to	 give	 compound	10	 as	
green	crystals	(Scheme	1	and	2).	Yield:	54%.	M.p.:	>300	oC.	FT‐
IR	(KBr,	cm‐1):	1798	(C=O)	lactone,	1669	(C=O)	chromone.	1H	
NMR	 (300	 MHz,	 DMSO‐d6,	 δ,	 ppm):	 7.90‐7.40	 (m,	 6H,	 Ar‐H),	
7.13	(s,	2H,	C7‐H	&	C9‐H).	13C	NMR	(75	MHz,	DMSO‐d6,	δ,	ppm):	
187.9	 (C‐10),	164.7	 (C‐1),	164.3	 (C‐8),	139.7	 (C‐16),	131.4	 (C‐
6),	 131.2	 (C‐5),	 127.8	 (C‐14),	 123.0	 (C‐13),	 122.2	 (C‐4),	 120.7	
(C‐12),	 120.6	 (C‐15),	 120.5	 (C‐11),	 120.4	 (C‐3),	 119.0	 (C‐2),	
106.0	(C‐9),	99.0	 (C‐7).	MS	(EI,	m/z,	%):	358	(M+.,	42.9).	Anal.	
calcd.	 for	 C18H8Cl2O4:	 C,	 60.19;	 H,	 2.25;	 Cl,	 19.74.	 Found:	 C,	
60.04;	H,	2.12;	Cl,	19.53%.	
	
2.2.10.	2‐(6,8‐Dichloro‐4‐oxo‐4H‐chromen‐2‐yl)‐2H‐indene‐
1,3‐dione	(11)	
	
To	 a	 suspension	 of	 compound	 10	 (1.4	 mmol,	 0.5	 g)	 in	
absolute	 methanol	 (10	 mL)	 and	 solution	 of	 methoxide	
(prepared	 by	 reaction	 0.5	 g	 sodium	 metal	 with	 10	 mL	 of	
absolute	 methanol)	 was	 added.	 The	 solution	 was	 heated	 at	
reflux	for	5	h,	left	to	cool,	diluted	with	water	and	acidified	with	
cold	 dilute	 H2SO4,	 the	 solid	 formed	 was	 collected,	 dried	 and	
recrystallized	from	ethanol	and	toluene	to	afford	6,8‐dichloro‐
2‐(4‐oxochroman‐3‐yl)‐4H‐chromen‐4‐one	 (11)	 as	 brown	
crystals	(Scheme	1).	Yield:	89%.	M.p.:	>300	oC.	FT‐IR	(KBr,	cm‐
1):	 1707	(C=O)	 indandione,	 1642	(C=O)	 chromone.	 1H	 NMR	
(300	MHz,	DMSO‐d6,	δ,	ppm):	7.99‐7.51	(m,	6H,	Ar‐H),	6.27	(s,	
1H,	C‐3),	5.15	(s,	1H,	C‐9).	Anal.	calcd.	for	C18H8Cl2O4:	C,	60.19;	
H,	2.25;	Cl,	19.74.	Found:	C,	60.01;	H,	2.16;	Cl,	19.64%.	
	
2.2.11.	1‐(3,5‐Dichloro‐2‐hydroxyphenyl)‐3‐hydroxybut‐2‐
en‐1‐one	(13)	 
	
To	a	solution	of	2‐methylchromone	derivative	2	(9	mmol,	2	
g)	in	diethyl	ether	(50	mL),	sodium	ethoxid	solution	(prepared	
by	 reaction	 1	 g	 of	 sodium	 metal	 in	 30	 mL	 of	 absolute)	 was	
added.	The	reaction	mixture	was	shaken	in	tightly	closed	vessel	
for	2	h,	kept	at	room	temperature	 for	72	h.	The	solid	product	
was	collected,	washed	with	dry	diethyl	ether	and	acidified	with	
cold	10%	acetic	acid	.The	solid	crude	product	was	collected	by	
suction,	 dried	 and	 then	 recrystallized	 from	 light	 petroleum	
ether	(B.p.:	40‐60	oC)	 to	give	compound	13	 as	orange	crystals	
(Scheme	 1).	 Yield:	 14%.	 M.p.:	 107‐108	 oC.	 FT‐IR	 (KBr,	 cm‐1):	
3435(OH),	 1642	 (C=O)	 (α,β‐unsaturated	 ketone).	 1H	 NMR	
(300	MHz,	CDCl3,	δ,	ppm):	14.73	(s,	1H,	OH	enol,	exchangeable),	
12.59	(s,	1H,	OH	phenolic,	exchangeable),	7.55‐7.53	(m,	2H,	Ar‐
H),	 6.11	 (s,	 1H,	CH=C‐OH),	 2.35	 (s,	 3H,	CH3).	MS	 (EI,	m/z,	%):		
247	(M+1 ,	30.0).	Anal.	calcd.	for	C10H8Cl2O3:	C,	48.61;	H,	3.26;	
Cl,	28.70.	Found:	C,	48.49;	H,	3.14;	Cl,	28.65%.	
	
2.2.12.	6,8‐Dichloro‐2‐methyl‐4H‐thiochromene‐4‐thione	
(15)		
	
A	 mixture	 of	 2‐methylchromone	 2	 (5	 mmol,	 1.14	 g)	 and	
phosphorous	pentasulfied	(25	mmol,	0.55	g)	in	dry	toluene	(30	
mL)	 was	 heated	 at	 reflux	 for	 2	 h.	 The	 reaction	 solution	 was	
filtered	off	while	hot	and	the	filtrate	was	left	to	cool.	The	solid	
that	separated	out	was	collected,	dried	and	recrystallized	from	
light	 petroleum	 ether	 (B.p.:	 80‐100	 oC)	 and	 benzene	 to	 give	
compound	15	as	red	crystals	(Scheme	3).	Yield:	89%.	M.p.:	177‐
178	 oC.	FT‐IR	 (KBr,	 cm‐1):	 1613	(C=C),	1377	(C=S).	 1H	NMR	
(300	MHz,	CDCl3,	δ,	ppm):	8.44	(s,	1H,	Ar‐H),	7.72	(s,	1H,	Ar‐H),	
7.15	(s,	1H,	thiopyran	ring),	2.39	(s,	3H,	CH3).	MS	(EI,	m/z,	%):	
260	(M+1 ,	4.2).	Anal.	calcd.	 for	C10H6Cl2S2:	C,	45.98;	H,	2.32;	
Cl,	27.15;	S,	24.55.	Found:	C,	45.87;	H,	2.16;	Cl,	27.07;	S,	24.43%.	
	
2.2.13.	2‐(6,8‐Dichloro‐2‐methyl‐4H‐chromene‐4‐ylidene)	
malononitrile	(16)	
	
A	mixture	of	 chromone	derivative	2	 (5	mmol,	 1.14	g)	 and	
malononitrile	 (5	 mmol,	 0.33	 g)	 in	 freshly	 distilled	 acetic	
anhydride	 (12.5	mL)	was	 heated	 under	 reflux	 for	 3	 h.,	 left	 to	
cool.	 Excess	 acetic	 anhydride	 was	 distilled	 off	 and	 the	 crude	
product	 was	 filtered	 and	 washed	 with	 water,	 dried	 and	 then	
recrystallized	 from	 ethanol	 to	 give	 malononitrile	 derivative	
(16)	 as	brown	crystals	 (Scheme	3).	Yield:	59%.	M.p.:	 121‐123	
oC.	FT‐IR	(KBr,	cm‐1):	2212	(C≡N),	1652	(C≡C).	1H	NMR	(300	
MHz,	DMSO,	δ,	ppm):	8.14	(s,	1H,	Ar‐H),	7.89	(s,	1H,	Ar‐H),	6.37	
(s,	1H,	C3‐H),	2.32	(s,	3H,	CH3).	Anal.	calcd.	for	C13H6Cl2N2O:	C,	
56.35;	H,	2.18;	Cl,	25.59;	N,	10.11.	Found:	C,	56.19;	H,	2.10;	Cl,	
25.45;	N,	10.03%.	
	
2.2.14.	2‐Amino‐3‐(6,8‐dichloro‐2‐methyl‐4H‐chromen‐4‐
ylidene)prop‐1‐ene‐1,1,3‐tricarbonitrile	(17)	
	
A	mixture	of	 chromone	derivative	2	 (5	mmol,	 1.14	g)	 and	
malononitrile	(10	mmol,	0.66	g)	in	ethanol	(20	mL)	in	presence	
of	few	drops	of	piperidine	was	heated	under	reflux	for	4	h.	The	
crude	 solid	 product	 that	 deposited	 was	 collected	 by	 suction,	
dried	 and	 then	 recrystallized	 from	 ethanol	 to	 give	 compound	
17	as	yellow	crystals	(Scheme	3).	Yield:	59%.	M.p.:	198‐200	oC.	
FT‐IR	(KBr,	cm‐1):	3411,	3322	(NH2),	2212	(C≡N).		
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1H	 NMR	 (300	 MHz,	 DMSO,	 δ,	 ppm):	 8.25	 (s,	 2H,	 NH2,	
exchangeable),	7.65	(s,	1H,	Ar‐H),	7.28	(s,	1H,	Ar‐H),	6.79	(s,	1H,	
C3‐H),	 2.32	 (s,	 3H,	 CH3).	 MS	 (EI,	m/z,	 %):	 317	 (	 M‐CN+H ,	
17.7).	Anal.	calcd.	 for	C16H8Cl2N4O:	C,	56.00;	H,	2.35;	Cl,	20.66;	
N,	16.33.	Found:	C,	55.92;	H,	2.17;	Cl,	20.49;	N,	16.29%.	
	
2.2.15.	2,4‐Dichloro‐6‐(5‐methyl‐1H‐pyrazol‐3‐yl)phenol	
(18a)	
	
A	 mixture	 of	 chromone	 derivative	 2	 (5	 mmol,	 1.14	 g)	 in	
ethanol	(20	mL),	hydrazine	hydrate	(10	mmol,	5	g),	ethanol	(10	
mL)	was	added.	The	reaction	mixture	was	heated	at	reflux	for	8	
h,	 left	 to	 cool	 .The	 solid	 product	 that	 formed	 was	 collected,	
dried	and	recrystallized	from	toluene	to	give	compound	18a	as	
grey	 crystals	 (Scheme	3).	 Yield:	 26%.	M.p.:	 207‐208	 oC.	 FT‐IR	
(KBr,	cm‐1):	3457	(OH),	3381	(NH).	1H	NMR	(300	MHz,	CDCl3,	
δ,	ppm):	7.42	(s,	1H,	NH,	exchangeable),	7.38‐7.22	(m,	2H,	Ar‐H	
and	 1H,	OH	 phenolic,	 exchangeable),	 6.43	 (s,	 1H,	H‐Pyrazole),	
2.43	 (s,	 3H,CH3).	 MS	 (EI,	m/z,	 %):	 246	 (M+4 ,	 40.0).	 Anal.	
calcd.	 for	 C10H8Cl2N2O:	 C,	 49.41;	 H,	 3.32; Cl,	 29.17;	 N,	 11.52.	
Found:	C,	46.34;	H,	Cl,	28.97;	3.97;	N,	6.64%.	
	
2.2.16.	2,4‐Dichloro‐6‐(5‐methyl‐1‐phenyl‐1H‐pyrazol‐3‐yl)	
phenol	(18b)		
	
To	a	solution	of	chromone	derivative	2	(5	mmol,	1.14	g)	in	
ethanol	 (20	mL),	 phenyl	 hydrazine(47	mmol,	 5	 g)	 in	 ethanol	
(10	mL)	was	added,	and	few	drops	from	acetic	acid	was	heated	
at	reflux	for	12	h	.	The	cooled	reaction	mixture	was	diluted	with	
water,	 and	 the	 precipitated	 solid	 was	 recrystallized	 from	
benzene	to	give	compound	18b	as	brown	crystals	(Scheme	3).	
Yield:	 91%.	 M.p.:	 172‐174	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 3487	 (OH),	
1595	(C=C).	 1H	NMR	(300	MHz,	CDCl3,	δ,	ppm):	7.34‐7.28	(m,	
7H,	 Ar‐H,	 1H,	 OH	 phenolic,	 exchangeable),	 6.37	 (s,	 1H,	 H‐
pyrazole),	 2.39	 (s,	 3H,	 CH3).	MS	 (EI,	m/z,	%):	 318	 (M+.,	 88.9).	
Anal.	 calcd.	 for	 C16H12Cl2N2O:	 C,	 60.21;	 H,	 3.79;	 Cl,	 22.21;	 N,	
8.78.	Found:	C,	60.10;	H,	3.59;	Cl,	22.09;	N,	8.63%.	
	
2.2.17.	2,4‐dichloro‐6‐(5‐methylisoxazol‐3‐yl)phenol	(19)	
	
A	 solution	 of	 chromone	 derivative	 2	 (prepared	 by	
dissolving	 2.2	 mmol,	 0.5	 g	 in	 3	 mL	 pyridine),	 hydroxylamine	
hydrochloride	(2.2	mmol,	0.15	g	in	1mL	water)	was	added.	The	
solution	 was	 heated	 at	 reflux	 for	 6	 h,	 allowed	 to	 cool	 and	
acidified	with	 cold	 diluted	 acetic	 acid.	 The	 solid	 product	 that	
formed	was	collected,	dried	and	recrystallized	from	toluene	to	
give	 isoxazol	19	as	grey	crystals	(Scheme	3).	Yield:	64%.	M.p.:	
196‐198	 oC.	 FT‐IR	 (KBr,	 cm‐1):	 3312	 (OH),	 3080	 (CH)	
(aromatic),	2960		(CH)	(aliphatic),	1610	(C=N).	1H	NMR	(300	
MHz,	CDCl3,	δ,	ppm):	7.82	(s,	1H,	Ar‐H),	7.42	(s,	1H,	Ar‐H),	6.71	
(s,	1H,	isoxazole	ring),	6.35	(s,	1H,	OH	phenolic,	exchangeable),	
2.39	(s,	3H,	CH3).	MS	(EI,	m/z,	%):	243	(M+.,	9.5).	Anal.	calcd.	for	
C10H7Cl2NO2:	 C,	 49.21;	 H,	 2.89;	 Cl,	 29.05;	 N,	 5.74.	 Found:	 C,	
49.11;	H,	2.78;	Cl,	28.95;	N,	5.58%.	
	
2.2.18.	1‐Acetyl‐6,8‐dichloro‐2‐methylquinolin‐4(1H)‐one	
(20)	
	
A	mixture	of	 chromone	derivative	2	 (5	mmol,	 1.14	g)	 and	
ammonium	acetate	(25	mmol,	1.5	g)	was	fused	for	3	h,	left	the	
mixture	 to	 cool	 and	 then	 poured	 into	 ice/water.	 The	 solid	
formed	was	collected	by	suction,	dried	and	then	recrystallized	
from	benzene	to	give	compound	20	as	yellow	crystals	(Scheme	
3).	Yield:	57%.	M.p.:	118‐120	oC.	FT‐IR	(KBr,	cm‐1):	1670	(CO)	
amide,	1651	(CO)	chromone.	MS	(EI,	m/z,	%):	269	(M+.,	20.0).	
Anal.	calcd.	for	C12H9Cl2NO2:	C,	53.36;	H,	3.36;	Cl,	26.25;	N,	5.19.	
Found:	C,	53.21;	H,	3.23;	Cl,	26.14;	N,	5.05%.	
	
	
2.3.	Measurement	of	antimicrobial	activity	using	the	disc	
diffusion	method	
	
A	 filter	 paper	 sterilized	 disc	 (diameter	 80	mm)	 saturated	
with	 measured	 quantity	 of	 the	 sample	 is	 placed	 on	 plate	
containing	 solid	 bacterial	 medium	 (nutrient	 agar	 broth)	 or	
fungal	medium	(Dox’s	medium)	which	has	been	heavily	seeded	
with	 the	 spore	 suspension	 of	 the	 tested	 organism.	 After	
inoculation,	 the	 diameter	 of	 the	 clear	 zone	 of	 inhibition	
surrounding	the	sample	is	taken	as	a	measure	of	the	inhibitory	
power	of	 the	 sample	against	 the	particular	 test	organism	[26‐
29].	
	
3.	Results	and	discussion	
	
3.1.	Synthesis	
	
6,8‐Dichloro‐2‐methyl‐4H‐chromen‐4‐one	 (2)	 was	 pre‐
pared	via	acid‐catalyzed	cyclodehydration	of	the	β‐diketone;	1‐
(3,5‐dichloro‐2‐hydroxyphenyl)butane‐1,3‐dione	 (1)	 [30].	 2‐
Methylchromones	 are	 typical	 substances	 containing	 an	 active	
methyl	 group	 due	 to	 the	 considerable	 stabilization	 of	 the	
produced	 carbanion	 by	 abstracting	 a	 proton	 from	 the	methyl	
group	 as	 a	 result	 of	 conjugation	 with	 the	 double	 bond	 and	
carbonyl	 functionality.	 Thus	 6,8‐dichloro‐2‐methyl‐4H‐
chromen‐4‐one	 (2)	 condensed	 under	 Knovenagel	 reaction	
conditions,	 with	 different	 aromatic	 aldehydes	 namely,	
benzaldehyde,	 4‐flurorobenzaldehyde	 and	 4‐methoxy	
benzaldehyde	 to	 afford	 the	 corresponding	 2‐styrylchromones	
(3a‐c)	[2,23,24,30‐33].	
Bromination	of	2‐styryl	chromone	(3a)	in	glacial	acetic	acid	
gave	 the	 corresponding	 vicinal	 dibromide	 (4).	 2‐Styryl	
chromones	 (3a‐c)	 are	 typical	 dienes	 which	 underwent	
cycloaddition	 reactions	 under	 Diels	 Alder	 reaction	 conditions	
with	 maleic	 anhydride	 and/or	 N‐arylmaleimides	 as	
dienophiles,	 to	 yield	 the	 initial	 adducts	 which	 subsequently	
underwent	dehydrogenation	to	afford	the	desired	adducts	(5a‐
g).	
Treatment	of	starting	chromone	2	with	thionyl	chloride	 in	
boiling	 benzene	 yielded	 6,8‐dichloro‐2‐(trichloromethyl)‐4H‐
chromen‐4‐one	 (6),	 which	 underwent	 heterocyclic	 systems	
transformation	 under	 the	 effect	 of	 aqueous	 alcoholic	 KOH	 to	
yield	coumarin	derivative	(7).	
Condensation	of	2‐methylchromone	2	with	diethyl	oxalate	
in	 the	 presence	 of	 sodium	 metal	 gave	 the	 corresponding	
pyruvate	 esters	 (8)	 [34],	which	exists	as	keto‐enol	 tautomers.	
The	 alkaline	 hydrolysis	 of	 compound	8	 afforded	 salicylic	 acid	
derivative	(9)	[22,24].	
When	 chromone	 2	 was	 allowed	 to	 react	 with	 phthalic	
anhydride	at	elevated	temperature	in	absence	of	solvents	in	the	
presence	of	 fused	anhydrous	sodium	acetate,	a	phthalide	(10)	
was	 formed	 and	 readily	 rearranged	 under	 the	 influence	 of	
alcoholic	 sodium	 methoxide	 solution	 to	 afford	 the	
corresponding	1,3‐indandione	derivative	(11)	[22,35].		
It	was	 claimed	 that	 [36]	 treatment	 of	 2‐methylchromones	
with	 an	 ethereal	 sodium	 ethoxide	 solution,	 afforded	 dimeric	
product	(12).	In	our	laboratory,	treatment	of	chromone	2	with	
the	 same	 reagent	 gave	 1‐(3,5‐dichloro‐2‐hydroxyphenyl)‐3‐
hydroxybut‐2‐en‐1‐one	 (13)	 was	 isolated	 as	 a	 sole	 product.	
According	 to	 our	 speculation,	 ethoxide	 acts	 as	 an	 oxygen	
nucleophile	not	as	a	base	and	attacks	at	C‐2	with	ring	opening	
followed	 by	 hydrolysis.	 The	 structure	 of	 compound	 13	 was	
ascertained	from	elemental	analysis	as	well	as	spectral	data	(IR,	
1H	NMR	and	MS)	(Scheme	1).	
Thiation	of	chromone	2	is	an	interesting	point	as	we	obtain	
results	 which	 are	 contradictory	 with	 the	 previously	 reported	
ones	 [23,37‐39].	 All	 these	 publications	 have	 been	 previously	
reported	 to	 provide	 the	 monothio	 compound;	 whether	 the	
thiation	was	 carried	 out	 by	 P2S5/dry	 toluene	 or	 xylene	 or	 by	
Lawesson's	 reagent.	 6,8‐Dichloro‐2‐methyl‐4H‐chromene‐4‐
thione	 (14)	 was	 believed	 to	 be	 obtained	 via	 thiation	 of	 6,8‐
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dichloro‐2‐methyl‐4H‐chromen‐4‐one	 (2)	 with	 phosphorus	
pentasulfide	 in	 dry	 toluene.	 However,	 the	 6,8‐dichloro‐2‐
methyl‐4H‐thiochromene‐4‐thione	(15)	was	the	sole	product.	
The	 reaction	 of	 2‐methylchromones	with	malononitrile	 as	
an	example	of	compounds	containing	active	methylene	groups	
yields	a	product,	which	depends	upon	the	reaction	conditions.	
Thus,	 when	 2‐methylchromone	 2	 was	 allowed	 to	 react	 with	
malononitrile	 (1:1)	 in	 boiling	 acetic	 anhydride,	 the	
corresponding	 condensation	 product	 16	 was	 obtained	 [24].	
The	product	16	 is	formed	via	carbon	nucleophile	attack	of	the	
active	 methylene	 on	 the	 electronically	 deficient	 carbonyl	
carbon	of	chromone	nucleus.	
On	the	other	hand,	when	2‐methylchromone,	2	was	allowed	
to	 react	 with	 excess	 malononitrile	 in	 refluxing	 ethanol	
containing	few	drops	of	piperidine,	 the	product	was	 identified	
to	be	the	tricarbonitrile	(17)	which	is	formed	from	the	attack	of	
a	 second	 malononitrile	 molecule	 on	 the	 initially	 formed	
condensation	 intermediate	 of	 type	 (16).	 The	 attack	 occurs	 at	
one	 cyano	 group	 but	 not	 on	 both	 probably	 due	 to	 steric	
hindrance.	 The	 present	 work	 extended	 to	 investigate	 the	
behaviour	 of	 6,8‐dichloro‐2‐methyl‐4H‐chromen‐4‐one	 (2)	
towards	 nitrogen	 nucleophiles	 namely,	 hydrazine	 hydrate,	
phenyl	 hydrazine,	 hydroxyl	 amine	 hydrochloride	 and	
ammonium	 acetate.	 Thus	 hydrazinolysis	 of	 the	 chromone	
derivative	2	with	hydrazines	namely	hydrazine	hydrate,	phenyl	
hydrazine	in	boiling	pyridine	underwent	cleavage	of	the	pyran	
ring	 and	 afforded	 the	 corresponding	 pyrazoles	 (18a,b),	
respectively	[22,24,40].	
When	 6,8‐dichloro‐2‐methyl‐4H‐chromen‐4‐one,	 2	 was	
allowed	 to	 react	with	 excess	 hydroxylamine	 hydrochloride,	 it	
gave	the	isoxazol	derivative	19	via	the	attack	of	nitrogen	atom	
by	its	lone	pair	on	C‐2	of	chromone	moiety	leading	to	chromone	
ring	 cleavage.	 Both	 compounds	 18	 and	 19	 have	 two	
indistinguished	probable	structures	obtained	from	the	mode	of	
the	 nitrogen	 nucleophile	 attack	 on	 two	 competitive	
electrophilic	centers	of	the	substrate	(2).	The	latter	are	the	C‐2	
and	 C‐4	 of	 chromone	 moiety.	 1‐Acetyl‐6,8‐dichloro‐2‐
methylquinolin‐4(1H)‐one	(20)	was	formed	when	a	mixture	of	
2‐methylchromone	derivative	 (2)	and	ammonium	acetate	was	
fused	for	3h	in	absence	of	solvents	(Scheme	3).	
	
3.2.	Biological	Activity	
	
Antibacterial	 and	 antifungal	 activities	 of	 some	 selected	
synthesized	compounds	were	screened	using	the	disc	diffusion	
method.	The	experiments	were	performed	using	test	bacterial	
organisms	 belonging	 to	 the	 Gram‐positive	 and	 Gram‐negative	
groups	 namely	 Staphylococcus	 aureus	 and	 Escherichia	 coil	
respectively	 as	well	 as	Candida	albicans	 and	Aspergillus	 flavus	
as	tested	fungi.	Compounds	under	investigation	were	dissolved	
in	 DMSO	 as	 an	 inactive	 solvent	 towards	 all	 microorganisms.	
The	concentration	of	DMSO	solutions	was	0.2	mg/	mL	
Table	1	and	Figure	1	revealed	the	inhibitory	activity	of	nine	
selected	 compounds,	 3b,	 4,	 5g,	 9,	 10,	 13,	 15,	 18b	 and	 19	
derived	from	the	starting	2‐methylchromone	(2).	The	following	
points	have	been	noticed:	
(1)	 The	 compounds	under	 investigation	 have	more	 inhibitory	
action	 than	 the	 starting	 compound	 except	 compounds,	3b,	5g	
and	15.		
(2)	 Compound	 13	 showed	 inhibitory	 effect	 against	 Gram‐
positive	as	the	same	as	standard	compound.	
(3)	 The	 tested	 compounds	 could	 be	 classified,	 according	 to	
their	activities	into	four	groups:		
a)	Group	1:	Compound	3,5‐dichloro‐2‐hydroxybenzoic	acid	
(9)	 showed	 inhibitory	 effect	 against	 all	 the	 tested	
microorganisms.	
b)	Group	2:	Compound	5g	did	not	have	any	inhibitory	effect	
except	against	Candida	albicans.		
c)	 Group	 3:	 Compounds	 18b,	 13	 inhibited	 the	 growth	 of	
only	three	of	the	tested	microorganisms.		
d)	Group	4:	The	other	six	compounds	(2,	3b, 4,	10,	   15 and	
19)	 inhibited	 only	 the	 growth	 of	 bacteria	 strands	 of	 the	
tested	microorganisms.	
	
Table	1.	The	inhibition	zone	diameters	of	some	selected	compounds	against	
tested	organisms.	
Sample/Standard 
Inhibition	zone	diameter	(mm/mg	sample)
Escherichia	
coli	(G‐)	
Staphylococcus	
aureus	(G+) 
Aspergillus	
flavus	
(Fungus)
Candida	
albicans	
(Fungus)
2 13.0 14.0 0.0	 0.0
3b 12.0 12.0 0.0	 0.0
4 12.0 15.0 0.0	 0.0
5g 0.0 0.0 0.0	 13.0
9 20.0 21.0 11.0 12.0
10 13.0 15.0 0.0 0.0
13 22.0	 30.0	 14.0	 0.0	
15 12.0	 13.0	 0.0	 0.0	
18b 14.0 17.0 0.0	 11.0
19 15.0	 18.0	 0.0	 0.0	
Tetracycline	(X)	 32.0	 30.0 -	 -
Amphotericin B	(Y) - - 19.0	 21.0
DMSO 0.0 0.0 0.0 0.0
	
	
0
5
10
15
20
25
30
35
2 3b 4 5g 9 10 13 15 18b 19 X Y
Compounds
In
h
ib
it
io
n
 z
o
n
e
, m
m
E.coli
S.aureus
A.flavus
C.albicans
	
Figure	 1. The	 effect	 of	 some	 selected	 compounds	 on	 inhibition	 zone	
diameters	against	tested	organisms.	
	
4.	Conclusions	
	
2‐Methylchromones	could	be	utilized	to	construct	a	variety	
of	 heterocyclic	 systems	 such	 as	 pyrazole,	 isoxazol	 and	
quinolinone.	 The	 phthalide	 and	 the	 2‐trichloromethyl	
derivative	 of	 the	 chromone	 exhibited	 two	 examples	 of	
heterocyclic‐alicyclic	 and	 heterocyclic‐heterocyclic	 trans‐
formations.	 Thiation	 of	 2‐methylchromone	 interestingly	
provides	 a	 dithiated	 product	 instead	 of	 the	 literature	
monothiated	one.		
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